Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.
With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.
Financial Results:
Alembic Ltd reported Revenues for Q2FY24 of ₹32.00 Crores down from ₹37.00 Crore year on year, a fall of 13.51%.
Total Expenses for Q2FY24 of ₹24.00 Crores down from ₹28.00 Crores year on year, a fall of 14.29%.
Consolidated Net Profit of ₹91.00 Crores down 20.87% from ₹115.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹3.53, down 21.38% from ₹4.49 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.